15 research outputs found

    Executive functioning in children with an autism spectrum disorder: Can we differentiate

    Get PDF
    The aim of this study was to investigate whether children with high-functioning autism (HFA), Asperger's syndrome (AS), and pervasive developmental disorder not otherwise specified (PDDNOS) can be differentiated from each other and from normal controls on their neurocognitive executive functioning (EF) profile. Children with HFA and AS showed the most EF deficits. The EF profile of the PDDNOS group was more disturbed that the normal control group, but was less disturbed than the profile of the HFA and AS groups. Little difference was found between the three PDD subtypes with respect to EF. This study supports the view that executive dysfunctioning plays an important role in autism. The usefulness of a distinction between different PDD subtypes was not demonstrated. © 2006 Springer Science+Business Media, Inc

    Friendship, loneliness and depression in adolescents with Asperger's Syndrome

    No full text
    This study investigated the relation between friendship, loneliness and depressive symptoms in adolescents with Asperger's Syndrome (AS). Thirty-five adolescents with AS and 35 controls matched on chronological age, school year and gender distribution, completed questionnaires designed to ascertain the quality of their best-friendship, motivation for developing friendships., feelings of loneliness and depressive symptomatology. Relative to the comparison group, the participants with AS reported poorer quality of best-friendship and less motivation to develop friendships. The Individuals with AS displayed higher levels of loneliness and depressive symptoms, with loneliness being negatively correlated with the quality of their best-friendship. Increased levels of loneliness in the adolescents with AS was predicted by the extent to which their best-friendships were characterized by high levels of conflict/betrayal. Increased depressive symptoms in the adolescents with AS were also predicted by this factor. The findings indicate that Increased levels of negative affect may be related to the poor quality of social relationships often reported in this population. (C) 2008 The Association for Professionals in Services for Adolescents

    An evaluation of community pharmacists’ understanding of autism spectrum disorder: a cross-sectional study in Western Australia

    No full text
    © 2019 Royal Pharmaceutical Society Objectives: To assess the knowledge and understanding of autism spectrum disorder (ASD) by community pharmacists, across Western Australia (WA) and evaluate the extent to which they incorporate ASD friendly practices in their pharmacy. Methods: A cross-sectional study involved a postal questionnaire sent to a stratified random sample of 250 community pharmacies across WA. A score of ≥10/13 (≥76.9%) appropriate responses to selected questions was considered an indication of ‘good knowledge’ of ASD. Univariate associations between ‘good knowledge’ and variables in the questionnaire were analysed using chi-square statistics, and multivariate analysis was performed using a logistic regression model. Demographic data relating to the pharmacy were used to determine the likelihood it was ASD friendly. Key findings: Overall, 97/250 (38.8%) questionnaires were returned. There were 34/96 (35.4%) respondents classified as having ‘good knowledge’. Stigma surrounding ASD was the single best indicator of ‘good knowledge’ (P < 0.0001). None of the respondents indicated they catered specifically for ASD, and 38/97 (39.2%) reported that no changes were needed to their pharmacy to improve accessibility. There were a number of demographic features that increased the likelihood that pharmacies had the potential to be ASD friendly. Conclusions: Pharmacists overall had a basic understanding of ASD. Pharmacists who identified that stigma surrounding ASD existed in the community were more likely to achieve ‘good knowledge’. There was a reluctance to improve pharmacy accessibility to patients with ASD. Pharmacists did not appear to incorporate ASD beneficial practices into their pharmacy and pharmacy environment
    corecore